N~2~-[(2S,3Z)-2-({(2S)-2-[(3R)-3-amino-2-oxopyrrolidin-1-yl]-4-methylpentanoyl}amino)-4-(methylsulfanyl)but-3-enoyl]-L-glutaminyl-N-[(1S)-1-benzyl-2-oxoethyl]-L-tryptophanamide

CAS125989-10-8

N~2~-[(2S,3Z)-2-({(2S)-2-[(3R)-3-amino-2-oxopyrrolidin-1-yl]-4-methylpentanoyl}amino)-4-(methylsulfanyl)but-3-enoyl]-L-glutaminyl-N-[(1S)-1-benzyl-2-oxoethyl]-L-tryptophanamide (CAS 125989-10-8, C40H52N8O7S) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.

Chemical structure of N~2~-[(2S,3Z)-2-({(2S)-2-[(3R)-3-amino-2-oxopyrrolidin-1-yl]-4-methylpentanoyl}amino)-4-(methylsulfanyl)but-3-enoyl]-L-glutaminyl-N-[(1S)-1-benzyl-2-oxoethyl]-L-tryptophanamide
C40H52N8O7S · 788.96 g/mol
CAS No.
125989-10-8
Formula
C40H52N8O7S
Mol. weight
788.96 g/mol

Chemical Specifications

Identifiers

CAS number 125989-10-8
Product name N~2~-[(2S,3Z)-2-({(2S)-2-[(3R)-3-amino-2-oxopyrrolidin-1-yl]-4-methylpentanoyl}amino)-4-(methylsulfanyl)but-3-enoyl]-L-glutaminyl-N-[(1S)-1-benzyl-2-oxoethyl]-L-tryptophanamide
Synonyms L-Phenylalanine,N-[2-(3-amino-2-oxo-1-pyrrolidinyl)-4-methyl-1-oxopentyl]-L-methionyl-L-glutaminyl-L-tryptophyl-,cyclic (4®1)-peptide, [S-(R*,S*)]-; 1,4,7,10,13,16-Hexaazabicyclo[15.2.1]eicosane, cyclic peptide deriv.; L 659837
Molecular formula C40H52N8O7S
Molecular weight 788.96 g/mol

Physical and chemical properties

Boiling Point 683.5 ( ℃ )

Packaging, Storage & Transport

Available pack sizes 5kg, 1kg, 500g, 100g, 50g, 10g

Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.

Frequently Asked Questions

What is the CAS number of N~2~-[(2S,3Z)-2-({(2S)-2-[(3R)-3-amino-2-oxopyrrolidin-1-yl]-4-methylpentanoyl}amino)-4-(methylsulfanyl)but-3-enoyl]-L-glutaminyl-N-[(1S)-1-benzyl-2-oxoethyl]-L-tryptophanamide?

The CAS Registry Number of N~2~-[(2S,3Z)-2-({(2S)-2-[(3R)-3-amino-2-oxopyrrolidin-1-yl]-4-methylpentanoyl}amino)-4-(methylsulfanyl)but-3-enoyl]-L-glutaminyl-N-[(1S)-1-benzyl-2-oxoethyl]-L-tryptophanamide is 125989-10-8. N~2~-[(2S,3Z)-2-({(2S)-2-[(3R)-3-amino-2-oxopyrrolidin-1-yl]-4-methylpentanoyl}amino)-4-(methylsulfanyl)but-3-enoyl]-L-glutaminyl-N-[(1S)-1-benzyl-2-oxoethyl]-L-tryptophanamide is also known as L-Phenylalanine,N-[2-(3-amino-2-oxo-1-pyrrolidinyl)-4-methyl-1-oxopentyl]-L-methionyl-L-glutaminyl-L-tryptophyl-,cyclic (4®1)-peptide, [S-(R*,S*)]-; 1,4,7,10,13,16-Hexaazabicyclo[15.2.1]eicosane, cyclic peptide deriv.; L 659837.

What is the molecular formula and molecular weight of N~2~-[(2S,3Z)-2-({(2S)-2-[(3R)-3-amino-2-oxopyrrolidin-1-yl]-4-methylpentanoyl}amino)-4-(methylsulfanyl)but-3-enoyl]-L-glutaminyl-N-[(1S)-1-benzyl-2-oxoethyl]-L-tryptophanamide?

The molecular formula of N~2~-[(2S,3Z)-2-({(2S)-2-[(3R)-3-amino-2-oxopyrrolidin-1-yl]-4-methylpentanoyl}amino)-4-(methylsulfanyl)but-3-enoyl]-L-glutaminyl-N-[(1S)-1-benzyl-2-oxoethyl]-L-tryptophanamide is C40H52N8O7S, and its molecular weight is 788.96 g/mol.

How can I request a quotation for N~2~-[(2S,3Z)-2-({(2S)-2-[(3R)-3-amino-2-oxopyrrolidin-1-yl]-4-methylpentanoyl}amino)-4-(methylsulfanyl)but-3-enoyl]-L-glutaminyl-N-[(1S)-1-benzyl-2-oxoethyl]-L-tryptophanamide?

Send an inquiry for N~2~-[(2S,3Z)-2-({(2S)-2-[(3R)-3-amino-2-oxopyrrolidin-1-yl]-4-methylpentanoyl}amino)-4-(methylsulfanyl)but-3-enoyl]-L-glutaminyl-N-[(1S)-1-benzyl-2-oxoethyl]-L-tryptophanamide (CAS 125989-10-8) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.

Request a Quote for N~2~-[(2S,3Z)-2-({(2S)-2-[(3R)-3-amino-2-oxopyrrolidin-1-yl]-4-methylpentanoyl}amino)-4-(methylsulfanyl)but-3-enoyl]-L-glutaminyl-N-[(1S)-1-benzyl-2-oxoethyl]-L-tryptophanamide

Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.

Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.